If you take them together, you might experience an additive effect. This means the two substances together create a stronger reaction than either would on its own
The patient type segmentation covers insured patients and uninsured patients
Hulst AH, Plummer MP, Hollmann MW, DeVries JH, Preckel B, Deane AM et al (2018) Systematic review of incretin therapy during peri-operative and intensive care
Data from the Phase 2 programme (NEJM, 2023) provide an initial picture of its tolerability, which broadly mirrors that of other incretin-based therapies, with some additional considerations related to its glucagon receptor activity
Data from a breast-feeding woman at 17 days postpartum did not indicate any adverse effects on the breast-fed infant
Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH